Skip to main content
. 2021 Mar 8;14(3):236. doi: 10.3390/ph14030236
ADCC antibody-dependent cell-mediated cytotoxicity
APCs antigen-presenting cells
Cat cathepsin
CatG cathepsin G
CCL1 chemokine C-C motif ligand 1
CSPG4 chondroitin sulfate proteoglycan 4
DCs dendritic cells
D-MMSN doxorubicin-loaded magnetic mesoporous silica nanoparticles
DNAM-1 DNAX accessory molecule 1
DNRII TGF-β-dominant-negative receptor II
EGFR epidermal growth factor receptor
EGFRvIII epidermal growth factor receptor variant III
GM-CSF granulocyte macrophage colony-stimulating factor
HLA human leukocyte antigen
IL-2 interleukin 2
ITAM immunoreceptor tyrosine-based activation motif
KIRs killer immunoglobulin-like receptors
MDSCs myeloid-derived suppressor cells
MHC I major histocompatibility complex class I
NETs neutrophil extracellular traps
MICA MHC class I chain-related protein A
MICB MHC class I chain-related protein B
NCR natural cytotoxicity receptor
NK cells natural killer cells
NKG2D natural killer group 2D activating receptor
NKG2DL natural killer group 2D ligands
NSPs neutrophil serine proteases
PBMCs peripheral blood mononuclear cells
TCR T cell receptor
TGF-β transforming growth factor beta
TGN trans-Golgi network
Th cells T helper cells
TME tumor microenvironment
TNF-α tumor necrosis factor α
TRAIL TNF-related apoptosis-inducing ligand
Tregs T regulatory cells
ULBP1–6 UL 16 binding protein 1–6